Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics

Singh, Bhupinder; Pahuja, Sonia; Kapil, Rishi; Ahuja, Naveen

doi:10.2478/v10007-009-0005-z

Abstract

The current study involves development of oral bioadhesive hydrophilic matrices of hydralazine hydrochloride, and optimization of their in vitro drug release profile and ex vivo bioadhesion against porcine gastric mucosa. A 3² central composite design was employed to systematically optimize the drug delivery formulations containing two polymers, viz., carbomer and hydroxypropyl methyl cellulose. Response surface plots were drawn and optimum formulations were selected by brute force searches. Validation of the formulation optimization study indicated a very high degree of prognostic ability. The study successfully undertook the development of an optimized once-a-day formulation of hydralazine with excellent bioadhesive and controlled release characteristics.

References

Y. W. Chien, Rate-control drug delivery systems: Controlled release vs. sustained release, Med. Prog. Technol. 15 (1989) 21-46.
Search in Google Scholar
Y. Song, Y. Wang, R. Thakur, V. M. Meidan and B. Michniak, Mucosal drug delivery: membranes, methodologies, and applications, Crit. Rev. Ther. Drug Carrier Syst. 21 (2004) 195-256; DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i3.20.10.1615/CritRevTherDrugCarrierSyst.v21.i3.20
Search in Google Scholar
B. Singh, S. K. Chakkal and N. Ahuja, Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology, AAPS PharmSciTech 7 (2006) E1-E10; DOI: 10.1208/pt070103.10.1208/pt07010328290018
Search in Google Scholar
J. A. Oates and N. J. Brown, Antihypertensive Agents and the Drug Therapy of Hypertension, in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th ed. (Ed. J. G. Hardman and L. E. Limbird), Mc Graw Hill Medical Publishing Division, New York 2001, pp. 871-900.
Search in Google Scholar
K. Wulff, K. Lenz, A. R. Krogsgaard and B. Holst, Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations, Ugeskr. Laeger. 142 (1980) 1862-1865.
Search in Google Scholar
T. Talseth, P. Fauchald and J. F. Pape, Hydralazine slow-release: Observations on serum profile and clinical efficacy in man, Curr. Ther. Res. Clin. Exp. 21 (1977) 157-168.
Search in Google Scholar
J. Adir, S. M. Janda, C. L. Curry, R. E. Taylor, C. D. Poku and K. S. Rotenberg, Comparative efficacy and safety of immediate-release and controlled-release hydralazine in black hypertensive patients, Clin. Ther. 9 (1987) 640-650.
Search in Google Scholar
J. H. Silas, L. E. Ramsay and S. Freestone, Hydralazine once daily in hypertension, Br. Med. J. 284 (1982) 1602-1624.10.1136/bmj.284.6329.160214985426805621
Search in Google Scholar
B. Singh, R. Kumar and N. Ahuja, Optimizing drug delivery systems using systematic "design of experiments". Part I: fundamental aspects, Crit. Rev. Ther. Drug Carrier Syst. 22 (2005) 27-105; DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20.10.1615/CritRevTherDrugCarrierSyst.v22.i1.20
Search in Google Scholar
United States Pharmacopoeia 27, National Formulary 22, USP Convention, Rockville 2004.
Search in Google Scholar
B. Singh and S. Singh, A compreshensive computer program for study of drug release kinetics from compressed matrices, Indian J. Pharm. Sci. 60 (1998) 313-316.
Search in Google Scholar
B. Singh, T. Kaur and S. Singh, Correction of raw dissolution data for loss of drug during sampling, Indian J. Pharm. Sci. 59 (1997) 196-199.
Search in Google Scholar
R. W. Korsemeyer, R. Gurny, E. Doelker, P. Buri and N. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 23-35.
Search in Google Scholar
B. Singh and N. Ahuja, Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters, Drug Dev. Ind. Pharm. 28 (2002) 431-442; DOI: 10.1081/DDC-120003004.10.1081/DDC-120003004
Search in Google Scholar
V. V. Yamsani, R. Gannu, C. Kolli, M. E. Rao and M. R. Yamsani, Development and in vitro evaluation of buccoadhesive carvedilol tablets, Acta Pharm. 57 (2007) 185-197; DOI: 10.2478/v10007-007-0015-7.10.2478/v10007-007-0015-717507315
Search in Google Scholar
A. O. Nur and J. S. Zhang, Captopril floating and/or bioadhesive tablets: design and release kinetics, Drug Dev. Ind. Pharm. 26 (2000) 965-969; DOI: 10.1081/DDC-100101323.10.1081/DDC-100101323
Search in Google Scholar
B. Singh, M. Dahiya, V. Saharan and N. Ahuja, Optimizing drug delivery systems using systematic ≫design of experiments≪. Part II: retrospect and prospects, Crit. Rev. Ther. Drug Carrier Syst. 22 (2005) 215-294; DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i3.10.10.1615/CritRevTherDrugCarrierSyst.v22.i3.10
Search in Google Scholar
J. B. Schwartz and R. E. Connor, Optimization Techniques in Pharmaceutical Formulation and Processing, in Modern Pharmaceutics (Eds. G. S. Banker and C. T. Rhodes), Marcel Dekker, New York 1996, pp. 727-752.
Search in Google Scholar
B. Singh, R. K. Gupta and N. Ahuja, Computer-assisted optimization of pharmaceutical formulations and processes, in Pharmaceutical Product Development (Ed. N. K. Jain), CBS Publishers, New Delhi 2006, pp. 273-318.
Search in Google Scholar
M. J. Vazquaz, B. Perez Macros, J. L. Gomez-Amoza and N. A. Peppas, Influence of technological variables on release of drugs from hydrophilic matrices, Drug Dev. Ind. Pharm. 18 (1992) 1355-1375.10.3109/03639049209046332
Search in Google Scholar
USFDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, U.S. Department of Health and Human Services, Food and Drug Administration: Center for Drug Evaluation and Research (CDER) (1997), Rockwille 1997.
Search in Google Scholar
S. Chopra, G. V. Patil and S. K. Motwani, Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design, Eur. J. Pharm. Biopharm. 66 (2007) 73-82; DOI: 10.1016/j.ejpb.2006.09.001.10.1016/j.ejpb.2006.09.00117056238
Search in Google Scholar
B. Perez-Marcos, J. L. Ford, D. J. Armstrong, P. N. Elliott, C. Rostron and J. E. Hogan, Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxypropylmethylcellulose K4M and carbopol 974, J. Pharm. Sci. 85 (1996) 330-334; DOI: 10.1021/js950359z.10.1021/js950359z
Search in Google Scholar
A. Nokhodchi, J. L. Ford and M. H. Rubinstein, Studies on the interaction between water and (hydroxypropyl)methylcellulose, J. Pharm. Sci. 86 (1997) 608-615; DOI: 10.1021/js960279a.10.1021/js960279a
Search in Google Scholar
G. Ponchel, F. Touchard, D. Duchene and N. A. Peppas, Bioadhesive analysis of controlled release systems. I. Fracture and interpenetration analysis in poly(acrylic acid) containing systems, J. Control. Rel. 5 (1987) 129-141; DOI: 10.1016/0168-3659(87)90004-6.10.1016/0168-3659(87)90004-6
Search in Google Scholar
F. Madson, K. Eberth and J. D. Smart, A rheological assessment of the nature of interactions between mucoadhesive polymers and a homogenised mucus gel, Biomaterials 19 (1998) 1083-1092.10.1016/S0142-9612(98)00037-4
Search in Google Scholar

Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics

Abstract

Paradigm

My account